UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FLI-1-driven regulation of endothelial cells in human diseases

Journal of translational medicine, 2024-08, Vol.22 (1), p.740-14, Article 740

2024

Volltextzugriff (PDF)

Association of Life's Essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003-2018

Scientific reports, 2024-07, Vol.14 (1), p.17188-10, Article 17188

2024

Volltextzugriff (PDF)

Association of volatile organic compound levels with chronic obstructive pulmonary diseases in NHANES 2013-2016

Scientific reports, 2024-07, Vol.14 (1), p.16085-11, Article 16085

2024

Volltextzugriff (PDF)

SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2

Frontiers in immunology, 2024-09, Vol.15

2024

Volltextzugriff (PDF)

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial

Signal transduction and targeted therapy, 2024-09, Vol.9 (1), p.248-9, Article 248

2024

Volltextzugriff (PDF)

ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer

Molecular carcinogenesis, 2024-09

2024

Volltextzugriff (PDF)

Reply to Comment on "Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008

American journal of ophthalmology, 2024-09, Vol.265, p.305-306

2024

Volltextzugriff (PDF)

Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors

Chinese journal of cancer research, 2024-08, Vol.36 (4), p.421-441

2024

Volltextzugriff (PDF)

CircARAP2 controls sMICA-induced NK cell desensitization by erasing CTCF/PRC2-induced suppression in early endosome marker RAB5A

Cellular and molecular life sciences : CMLS, 2024-12, Vol.81 (1), p.307, Article 307

2024

Volltextzugriff (PDF)

The application of immunonutrition in patients with cancer: current status and future perspectives

Holistic Integrative Oncology, 2024-09, Vol.3 (1), p.45, Article 45

2024

Volltextzugriff (PDF)

First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced melanoma: Safety and efficacy results from a phase I study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.9562-9562

2024

Volltextzugriff (PDF)

A phase 1 study of HRS-1167 (M9466), a highly selective PARP1 inhibitor, in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3154-3154

2024

Volltextzugriff (PDF)

Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials

Medicine (Baltimore), 2024-07, Vol.103 (27), p.e38459

2024

Volltextzugriff (PDF)

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer

Cancer cell, 2024-09, Vol.42 (9), p.1598-1613.e4

2024

Volltextzugriff (PDF)

Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial

Lung cancer (Amsterdam, Netherlands), 2024-09, Vol.195, p.107901, Article 107901

2024

Volltextzugriff (PDF)

Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study

The lancet respiratory medicine, 2024-09, Vol.12 (9), p.671-680

2024

Volltextzugriff (PDF)

Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial

JAMA oncology, 2024-09

2024

Volltextzugriff (PDF)

Garsorasib in patients with KRAS G12C -mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

The lancet respiratory medicine, 2024-08, Vol.12 (8), p.589

2024

Volltextzugriff (PDF)

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)

Cancer communications (London, England), 2024-07, Vol.44 (9), p.1005-1017

2024

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

Neu hinzugefügt... seit 90 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

FLI-1-driven regulation of endothelial cells in human diseases

Association of Life's Essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003-2018

Association of volatile organic compound levels with chronic obstructive pulmonary diseases in NHANES 2013-2016

SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial

ADAR1 Promotes Invasion and Migration and Inhibits Ferroptosis via the FAK/AKT Pathway in Colorectal Cancer

Reply to Comment on "Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008

Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors

CircARAP2 controls sMICA-induced NK cell desensitization by erasing CTCF/PRC2-induced suppression in early endosome marker RAB5A

The application of immunonutrition in patients with cancer: current status and future perspectives

First-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced melanoma: Safety and efficacy results from a phase I study

A phase 1 study of HRS-1167 (M9466), a highly selective PARP1 inhibitor, in patients (pts) with advanced solid tumors

Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials

Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer

Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial

Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study

Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial

Garsorasib in patients with KRAS G12C -mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)

Aktive Filter

Suchergebnisse filtern